Literature DB >> 19828788

Understanding the role of DISC1 in psychiatric disease and during normal development.

Nicholas J Brandon1, J Kirsty Millar, Carsten Korth, Hazel Sive, Karun K Singh, Akira Sawa.   

Abstract

The biology of schizophrenia is complex with multiple hypotheses (dopamine, glutamate, neurodevelopmental) well supported to underlie the disease. Pathways centered on the risk factor "disrupted in schizophrenia 1" (DISC1) may be able to explain and unite these disparate hypotheses and will be the topic of this mini-symposium preview. Nearly a decade after its original identification at the center of a translocation breakpoint in a large Scottish family that was associated with major psychiatric disease, we are starting to obtain credible insights into its function and role in disease etiology. This preview will highlight a number of exciting areas of current DISC1 research that are revealing roles for DISC1 during normal brain development and also in the disease state. Together these different threads will provide a timely and exciting overview of the DISC1 field and its potential in furthering our understanding of psychiatric diseases and in developing new therapies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19828788      PMCID: PMC6665304          DOI: 10.1523/JNEUROSCI.3355-09.2009

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  87 in total

1.  ASPM regulates Wnt signaling pathway activity in the developing brain.

Authors:  Joshua J Buchman; Omer Durak; Li-Huei Tsai
Journal:  Genes Dev       Date:  2011-09-15       Impact factor: 11.361

2.  Deletion of densin-180 results in abnormal behaviors associated with mental illness and reduces mGluR5 and DISC1 in the postsynaptic density fraction.

Authors:  Holly J Carlisle; Tinh N Luong; Andrew Medina-Marino; Leslie Schenker; Eugenia Khorosheva; Tim Indersmitten; Keith M Gunapala; Andrew D Steele; Thomas J O'Dell; Paul H Patterson; Mary B Kennedy
Journal:  J Neurosci       Date:  2011-11-09       Impact factor: 6.167

Review 3.  Cell biology of the BLOC-1 complex subunit dysbindin, a schizophrenia susceptibility gene.

Authors:  Ariana P Mullin; Avanti Gokhale; Jennifer Larimore; Victor Faundez
Journal:  Mol Neurobiol       Date:  2011-04-26       Impact factor: 5.590

4.  Toward new approaches to psychotic disorders: the NIMH Research Domain Criteria project.

Authors:  Bruce N Cuthbert; Thomas R Insel
Journal:  Schizophr Bull       Date:  2010-10-07       Impact factor: 9.306

Review 5.  Advancing schizophrenia drug discovery: optimizing rodent models to bridge the translational gap.

Authors:  Judith Pratt; Catherine Winchester; Neil Dawson; Brian Morris
Journal:  Nat Rev Drug Discov       Date:  2012-06-22       Impact factor: 84.694

Review 6.  Animal models of neuropsychiatric disorders.

Authors:  Eric J Nestler; Steven E Hyman
Journal:  Nat Neurosci       Date:  2010-09-27       Impact factor: 24.884

7.  Polymorphism of rs3737597 in DISC1 Gene on Chromosome 1q42.2 in sALS Patients: a Chinese Han Population Case-Control Study.

Authors:  Libin Deng; Liwei Huo; Jie Zhang; Xiaoli Tang; Zhujun Cheng; Gang Li; Xin Fang; Jinsong Xu; Xiong Zhang; Renshi Xu
Journal:  Mol Neurobiol       Date:  2016-04-07       Impact factor: 5.590

8.  The latent structure of psychiatric symptoms across mental disorders as measured with the PANSS and BPRS-18.

Authors:  Richard A Van Dorn; Sarah L Desmarais; Kevin J Grimm; Stephen J Tueller; Kiersten L Johnson; Brian G Sellers; Marvin S Swartz
Journal:  Psychiatry Res       Date:  2016-08-09       Impact factor: 3.222

9.  DISC1 regulates primary cilia that display specific dopamine receptors.

Authors:  Aaron Marley; Mark von Zastrow
Journal:  PLoS One       Date:  2010-05-28       Impact factor: 3.240

10.  No association between polymorphisms of WNT2 and schizophrenia in a Korean population.

Authors:  Hak-Jae Kim; Jin Kyung Park; Su Kang Kim; Sung Wook Kang; Jong Woo Kim; Hyun-Kyung Park; Ah-Rang Cho; Ji Young Song; Joo-Ho Chung
Journal:  BMC Med Genet       Date:  2010-05-24       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.